Nothing Special   »   [go: up one dir, main page]

EA201491531A1 - C-3 циклоалкенил тритерпеноиды, ингибирующие созревание вич - Google Patents

C-3 циклоалкенил тритерпеноиды, ингибирующие созревание вич

Info

Publication number
EA201491531A1
EA201491531A1 EA201491531A EA201491531A EA201491531A1 EA 201491531 A1 EA201491531 A1 EA 201491531A1 EA 201491531 A EA201491531 A EA 201491531A EA 201491531 A EA201491531 A EA 201491531A EA 201491531 A1 EA201491531 A1 EA 201491531A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cycloalkenyl
compounds
hiv maturation
inhibiting hiv
triterpenoids
Prior art date
Application number
EA201491531A
Other languages
English (en)
Other versions
EA024361B1 (ru
Inventor
Джейкоб Свидорски
Николас А. Минвелл
Алисия Регуейро-Рен
Син-Юэнь Сит
Цзи Чэнь
Янь Чэнь
Original Assignee
Бристол-Майерс Сквибб Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48946098&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201491531(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бристол-Майерс Сквибб Компани filed Critical Бристол-Майерс Сквибб Компани
Publication of EA201491531A1 publication Critical patent/EA201491531A1/ru
Publication of EA024361B1 publication Critical patent/EA024361B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Описаны соединения, имеющие лекарственную и биологическую активность, их фармацевтические композиции и способы их применения. В частности, предусмотрены С-3 циклоалкенил тритерпеноиды, которые обладают уникальной противовирусной активностью в качестве ингибиторов созревания ВИЧ, представленные соединениями формул I, II, III и IVгде X может представлять собой Cциклоалкил, Cциклоалкенил, Сспироциклоалкил, Сспироциклоалкенил, Cоксациклоалкил, Сдиоксациклоалкил, Cоксациклоалкенил, Cдиоксациклоалкенил, Cциклодиалкенил, Cоксациклодиалкенил, Cоксаспироциклоалкил и Cоксаспироциклоалкенил. Указанные соединения полезны для лечения ВИЧ и СПИД.
EA201491531A 2012-02-15 2013-02-13 C-3 циклоалкенил тритерпеноиды, ингибирующие созревание вич EA024361B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261599040P 2012-02-15 2012-02-15
US13/760,726 US8906889B2 (en) 2012-02-15 2013-02-06 C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
PCT/US2013/025897 WO2013123019A1 (en) 2012-02-15 2013-02-13 C-3 cycloalkenyl triterpenoids with hiv maturation inhibitory activity

Publications (2)

Publication Number Publication Date
EA201491531A1 true EA201491531A1 (ru) 2014-11-28
EA024361B1 EA024361B1 (ru) 2016-09-30

Family

ID=48946098

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201491531A EA024361B1 (ru) 2012-02-15 2013-02-13 C-3 циклоалкенил тритерпеноиды, ингибирующие созревание вич

Country Status (26)

Country Link
US (1) US8906889B2 (ru)
EP (1) EP2814834B1 (ru)
JP (1) JP6155285B2 (ru)
KR (1) KR20140123584A (ru)
CN (2) CN106046106A (ru)
AR (1) AR089996A1 (ru)
AU (1) AU2013221725B2 (ru)
BR (1) BR112014019672A8 (ru)
CA (1) CA2864656A1 (ru)
CL (1) CL2014002141A1 (ru)
CO (1) CO7061077A2 (ru)
EA (1) EA024361B1 (ru)
ES (1) ES2656984T3 (ru)
HK (1) HK1204608A1 (ru)
IL (1) IL234077A (ru)
MX (1) MX2014009235A (ru)
MY (1) MY166793A (ru)
NZ (1) NZ631408A (ru)
PE (1) PE20142315A1 (ru)
PH (1) PH12014501816A1 (ru)
PT (1) PT2814834T (ru)
SG (1) SG11201404748XA (ru)
TW (1) TW201336863A (ru)
UY (1) UY34627A (ru)
WO (1) WO2013123019A1 (ru)
ZA (1) ZA201406724B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889854B2 (en) 2012-05-07 2014-11-18 Bristol-Myers Squibb Company C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
SG11201505639SA (en) 2013-02-06 2015-08-28 Bristol Myers Squibb Co C-19 modified triterpenoids with hiv maturation inhibitory activity
BR112016023414B1 (pt) * 2014-04-11 2022-09-13 ViiV Healthcare UK (No.4) Limited Composto, composição farmacêutica, e, uso do composto
US9920090B2 (en) 2014-06-19 2018-03-20 VIIV Healthcare UK (No.5) Limited Betulinic acid derivatives with HIV maturation inhibitory activity
AU2015346314B2 (en) * 2014-11-14 2018-04-12 VIIV Healthcare UK (No.5) Limited Extended betulinic acid analogs
KR20170092581A (ko) 2014-11-14 2017-08-11 비브 헬스케어 유케이 (넘버5) 리미티드 Ｃ１７-아릴 치환된 베툴린산 유사체
WO2016077561A1 (en) 2014-11-14 2016-05-19 Bristol-Myers Squibb Company Oxolupene derivatives
CA2981056A1 (en) * 2015-04-14 2016-10-20 ViiV Healthcare UK (No.4) Limited Methods of producing an hiv maturation inhibitor
JP2018521093A (ja) 2015-07-28 2018-08-02 グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ Ｈｉｖ感染を予防または治療するためのベツイン誘導体
AU2016298667A1 (en) 2015-07-28 2018-02-22 Glaxosmithkline Intellectual Property (No.2) Limited Betuin derivatives for preventing or treating HIV infections
EP3353158A1 (en) 2015-09-24 2018-08-01 Glaxosmithkline Intellectual Property (No. 2) Limited Compounds with hiv maturation inhibitory activity
KR20180098675A (ko) * 2016-01-20 2018-09-04 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 Hiv 성숙 억제 활성을 갖는 루판의 아민 유도체
AR107512A1 (es) 2016-02-04 2018-05-09 VIIV HEALTHCARE UK Nº 5 LTD Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1
CN106905264B (zh) * 2017-04-12 2019-06-07 连云港杰瑞药业有限公司 一种合成阿扎拉韦中间体的方法
JP2020533377A (ja) * 2017-09-13 2020-11-19 エミオン インコーポレイテッドＥｍｍｙｏｎ， Ｉｎｃ． ウルソール酸モルホリン塩及びジエタノールアミン塩
US20210347813A1 (en) 2018-04-24 2021-11-11 Viiv Healthcare Uk (No. 5) Limited Compounds with hiv maturation inhibitory activity
CN109705189B (zh) * 2018-12-29 2020-06-05 中国医学科学院药用植物研究所 具有式i所示结构的三萜衍生物及其制备方法和应用
EP4248960A3 (en) 2019-02-11 2024-01-03 Hetero Labs Limited Novel triterpene derivatives as hiv inhibitors
WO2020229398A1 (de) 2019-05-14 2020-11-19 Bayer Aktiengesellschaft (1-alkenyl)-substituierte pyrazole und triazole als schädlingsbekämpfungsmittel

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413999A (en) 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
US5869535A (en) 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
US5962527A (en) 1995-03-21 1999-10-05 The Board Of Trustees Of The University Of Illinois Method and composition for treating cancers
US5679828A (en) 1995-06-05 1997-10-21 Biotech Research Labs, Inc. Betulinic acid and dihydrobetulinic acid derivatives and uses therefor
US20040110785A1 (en) 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US7365221B2 (en) 2002-09-26 2008-04-29 Panacos Pharmaceuticals, Inc. Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
WO2004089357A2 (en) 2003-04-02 2004-10-21 Regents Of The University Of Minnesota Anti-fungal formulation of triterpene and essential oil
US7745625B2 (en) 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
JP2007529544A (ja) 2004-03-17 2007-10-25 パナコス ファーマシューティカルズ， インコーポレイテッド ３−ｏ−（３’，３’−ジメチルスクシニル）ベツリン酸の製薬的な塩
TW200628161A (en) 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof
WO2008127364A2 (en) 2006-10-13 2008-10-23 Myriad Genetics, Inc. Antiviral compounds and use thereof
US20090105203A1 (en) 2006-10-16 2009-04-23 Myriad Genetics, Incorporated Compounds for treating viral infections
US20090062243A1 (en) 2007-08-03 2009-03-05 Advanced Life Sciences, Inc. Lupane-Type Triterpenoids Modified at 30-Position and Analogues Thereof
CN101981047A (zh) * 2008-01-03 2011-02-23 Viro化学制药公司 新的羽扇烷衍生物
WO2009100532A1 (en) 2008-02-14 2009-08-20 Virochem Pharma Inc. NOVEL 17ß LUPANE DERIVATIVES
US9067966B2 (en) 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
EA022790B1 (ru) 2009-12-17 2016-03-31 Мерк Шарп Энд Домэ Корп. Аминопиримидины в качестве syk ингибиторов
CA2801487C (en) * 2010-06-04 2017-12-05 Bristol-Myers Squibb Company Modified c-3 betulinic acid derivatives as hiv maturation inhibitors
JP5755731B2 (ja) 2010-06-04 2015-07-29 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｈｉｖ成熟阻害剤としての修飾ｃ−３ベツリン酸誘導体のｃ−２８アミド
SG186820A1 (en) 2010-07-02 2013-02-28 Gilead Sciences Inc Napht- 2 -ylacetic acid derivatives to treat aids
EP2670764B1 (en) * 2011-01-31 2015-09-02 Bristol-Myers Squibb Company C-28 amines of c-3 modified betulinic acid derivatives as hiv maturation inhibitors
MA34909B1 (fr) * 2011-01-31 2014-02-01 Bristol Myers Squibb Co Triterpénoïdes modifi2s en c-17 et c-3 presentant une activité inhibitrice de la maturation du vih
BR112014006559A2 (pt) 2011-09-21 2017-03-28 Bristol Myers Squibb Co derivados do ácido betulínico com atividade antiviral
US8889854B2 (en) 2012-05-07 2014-11-18 Bristol-Myers Squibb Company C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
SG11201505639SA (en) * 2013-02-06 2015-08-28 Bristol Myers Squibb Co C-19 modified triterpenoids with hiv maturation inhibitory activity

Also Published As

Publication number Publication date
ES2656984T3 (es) 2018-03-01
PT2814834T (pt) 2017-12-06
AU2013221725B2 (en) 2016-10-27
JP2015510515A (ja) 2015-04-09
UY34627A (es) 2013-09-02
HK1204608A1 (en) 2015-11-27
US8906889B2 (en) 2014-12-09
CO7061077A2 (es) 2014-09-19
CN104220451B (zh) 2016-06-29
AR089996A1 (es) 2014-10-01
EP2814834A1 (en) 2014-12-24
CN104220451A (zh) 2014-12-17
BR112014019672A2 (ru) 2017-06-20
ZA201406724B (en) 2016-08-31
IL234077A (en) 2016-11-30
BR112014019672A8 (pt) 2017-07-11
PE20142315A1 (es) 2015-01-16
SG11201404748XA (en) 2014-09-26
KR20140123584A (ko) 2014-10-22
JP6155285B2 (ja) 2017-06-28
NZ631408A (en) 2015-06-26
PH12014501816A1 (en) 2014-11-17
AU2013221725A1 (en) 2014-10-02
MX2014009235A (es) 2014-11-10
EA024361B1 (ru) 2016-09-30
CA2864656A1 (en) 2013-08-22
MY166793A (en) 2018-07-23
IL234077A0 (en) 2014-09-30
EP2814834B1 (en) 2017-09-13
US20130210787A1 (en) 2013-08-15
CN106046106A (zh) 2016-10-26
CL2014002141A1 (es) 2014-10-03
TW201336863A (zh) 2013-09-16
WO2013123019A1 (en) 2013-08-22

Similar Documents

Publication Publication Date Title
EA201491531A1 (ru) C-3 циклоалкенил тритерпеноиды, ингибирующие созревание вич
EA201391127A1 (ru) C-17 и c-3 модифицированные тритерпеноиды с ингибиторной активностью созревания вич
EA201270800A1 (ru) С-28 амиды модифицированных производных с-3 бетулиновой кислоты в качестве ингибиторов созревания вич
EA201492016A1 (ru) C-17 бициклические амины тритерпеноидов с ингибиторной активностью созревания вич
EA201270780A1 (ru) С-3 модифицированные производные бетулиновой кислоты в качестве ингибиторов созревания вич
EA201591406A1 (ru) C-19 модифицированные тритерпеноиды с ингибиторной активностью созревания вич
EA201591545A1 (ru) C-3 алкил- и алкенил-модифицированные производные бетулиновой кислоты
MX2016004492A (es) Inhibidores de la replicacion del virus de inmunodeficiencia humana (vih).
UA111770C2 (uk) Інгібітори бромдомену
ECSP13013021A (es) Compuestos de benzotiazol y su uso farmacéutico
EA201391098A1 (ru) C-28-амины c-3-модифицированных производных бетулиновой кислоты в качестве ингибиторов созревания вич
JO3357B1 (ar) مركبات إيميدازوبيروليدينون
EA201590450A1 (ru) Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b
UA113651C2 (xx) Макроциклічні пурини для лікування вірусних інфекцій
MX336381B (es) Boronatos como inhibidores de arginasa.
EA201492092A1 (ru) Соединения и композиции для ингибирования активности abl1, abl2 и bcr-abl1
MX343534B (es) Inhibidores de arginasa y sus aplicaciones terapeuticas.
EA201692003A1 (ru) Макроциклические производные пиримидина
UA113541C2 (xx) Заміщені піролідин-2-карбоксаміди
EA201692000A1 (ru) Макроциклические производные пиридина
EA201790576A1 (ru) Спироциклические ингибиторы катепсина с
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
EA201491013A1 (ru) Пиразиновые ингибиторы киназы
MX2014002936A (es) Nuevos derivados de acido betulinico con actividad antiviral.
MX363270B (es) Composiciones y metodos para inhibir la polimerasa viral.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM

PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU